- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Ethan P. Davis
News 21 results
Recognition
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
In the News · Source: Sacramento Business Journal
In the News · Source: Healthcare IT News
March 13, 2022
Ethan Davis explains how the pandemic has shifted the federal approach to fraud investigations and offers his predictions for this year
In the News · Source: The Federalist Society's Teleforum
March 7, 2022
Ethan Davis comments on the upcoming Supreme Court nominee’s influence on criminal law
Events 12 results
Webinar
February 1, 2022
Annual Healthcare Fraud Enforcement Update: What does 2022 Hold?
Webinar
November 30, 2021
Pharmaceutical and Medical Device Enforcement Developments & Trends in 2021
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Insights 27 results
Article · Source: U.S. Chamber of Commerce Litigation Center Blog
May 26, 2022
Top False Claims Act Developments
Client Alert
May 16, 2022
Cooperation Credit and Attorney-Client Privilege: The Implications of Coburn
Article · Source: U.S. Chamber of Commerce Litigation Center Blog
April 28, 2022
Top False Claims Act Developments
Client Alert
April 25, 2022
COVID-19 Health Care Fraud Enforcement on the Rise: What’s Ahead for the Life Sciences & Healthcare Industries